GIPPS for Primary Myelofibrosis

Loading...

References

  1. Damien Luque Paz. Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.. Blood advances, 2025
  2. Léa Sureau. Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis.. Blood cancer journal, 2021
  3. D. Luque Paz. Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.. Blood advances, 2021
  4. A. Tefferi. GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis. Leukemia, 2018
  5. A. Kuykendall. Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients. American Journal of Hematology, 2018
  6. A. Tefferi. Myelofibrosis Treatment Algorithm 2018. Blood Cancer Journal, 2018
  7. A. Tefferi. The Germline JAK2 GGCC (46/1) Haplotype and Survival Among 414 Molecularly-Annotated Patients with Primary Myelofibrosis. Blood, 2018
  8. Kebede Hussein. International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.. Blood, 2010